Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean sharif j[au] (77 results)?
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
Bandopadhyay P, D'Rozario R, Lahiri A, Sarif J, Ray Y, Paul SR, Roy R, Maiti R, Chaudhuri K, Bagchi S, Maiti A, Perwez MM, Sarkar BS, Roy D, Chakraborty R, Vasudevan JS, Sharma S, Biswas D, Maiti C, Saha B, Bhattacharya P, Pandey R, Chatterjee S, Paul S, Ganguly D. Bandopadhyay P, et al. Among authors: sarif j. J Infect Dis. 2021 Aug 16;224(4):565-574. doi: 10.1093/infdis/jiab010. J Infect Dis. 2021. PMID: 34398242 Free PMC article. Clinical Trial.
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells.
Raychaudhuri D, Bhattacharya R, Sinha BP, Liu CSC, Ghosh AR, Rahaman O, Bandopadhyay P, Sarif J, D'Rozario R, Paul S, Das A, Sarkar DK, Chattopadhyay S, Ganguly D. Raychaudhuri D, et al. Among authors: sarif j. Front Immunol. 2019 Aug 7;10:1878. doi: 10.3389/fimmu.2019.01878. eCollection 2019. Front Immunol. 2019. PMID: 31440253 Free PMC article.
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Sarif J, Raychaudhuri D, D'Rozario R, Bandopadhyay P, Singh P, Mehta P, Hoque MA, Sinha BP, Kushwaha M, Sahni S, Devi P, Chattopadhyay P, Paul SR, Ray Y, Chaudhuri K, Banerjee S, Majumdar D, Saha B, Sarkar BS, Bhattacharya P, Chatterjee S, Paul S, Ghosh P, Pandey R, Sengupta S, Ganguly D. Sarif J, et al. Front Immunol. 2021 Oct 28;12:738093. doi: 10.3389/fimmu.2021.738093. eCollection 2021. Front Immunol. 2021. PMID: 34777349 Free PMC article.
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Ray Y, Paul SR, Bandopadhyay P, D'Rozario R, Sarif J, Raychaudhuri D, Bhowmik D, Lahiri A, Vasudevan JS, Maurya R, Kanakan A, Sharma S, Kumar M, Singh P, Roy R, Chaudhury K, Maiti R, Bagchi S, Maiti A, Perwez MM, Mondal A, Tewari A, Mandal S, Roy A, Saha M, Biswas D, Maiti C, Bhaduri R, Chakraborty S, Sarkar BS, Haldar A, Saha B, Sengupta S, Pandey R, Chatterjee S, Bhattacharya P, Paul S, Ganguly D. Ray Y, et al. Among authors: sarif j. Nat Commun. 2022 Jan 19;13(1):383. doi: 10.1038/s41467-022-28064-7. Nat Commun. 2022. PMID: 35046397 Free PMC article. Clinical Trial.